STROUCKEN ALBERT P L
SEC CIK 1205438 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BAX | Baxter International | Dir | 40.8K | — | $453.1K | 5 | 2022-04-05 | 2023-03-20 |
Most active insiders at BAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Teaff James | Pres, CCS | — | — |
| 2 | Foster Julie | Pres, Front Line Care | — | — |
| 3 | Soriano Maria Cecilia | Group Pres, ITT, Pharma | — | — |
| 4 | Carlisle Cynthia | EVP, CHRO | — | — |
| 5 | Ampofo William A. II | Dir | — | — |
| 6 | Rasul Reazur | EVP, Group Pres, Healthcare | — | — |
| 7 | Hider Andrew P. | Pres, CEO, Dir | — | — |
| 8 | Rosenbloom David S. | EVP, GC | — | — |
| 9 | Wilkes David S. | Dir | — | — |
| 10 | Wallace Steven P. | Pres, Adv. Surgery | — | — |
STROUCKEN ALBERT P L made no open-market trades at BAX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-22 | 2023-03-20 | BAX | Baxter International | STROUCKEN ALBERT P L | Dir | M - OptEx | $36.93 | +3,930 | 40.8K | +11% | +$145.1K |
| D | 2023-03-22 | 2023-03-20 | BAX | Baxter International | STROUCKEN ALBERT P L | Dir | S - Sale+OE | $37.52 | -3,930 | 36.8K | -10% | -$147.5K |
| 2022-05-05 | 2022-05-03 | BAX | Baxter International | STROUCKEN ALBERT P L | Dir | A - Grant | $0.00 | +2,706 | 36.8K | +8% | $0 | |
| D | 2022-04-07 | 2022-04-05 | BAX | Baxter International | STROUCKEN ALBERT P L | Dir | M - OptEx | $29.52 | +4,020 | 38.1K | +12% | +$118.7K |
| DM | 2022-04-07 | 2022-04-05 | BAX | Baxter International | STROUCKEN ALBERT P L | Dir | S - Sale+OE | $76.02 | -4,020 | 35.3K | -10% | -$305.6K |
Purchase Sale Sale after option exercise All abbreviations